Lithuanian Lung Cancer Implementation Guide
0.0.1 - ci-build
Lithuanian Lung Cancer Implementation Guide, published by Lithuanian Medical Library. This guide is not an authorized publication; it is the continuous build for version 0.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7LT/ig-lt-lung/ and changes regularly. See the Directory of published versions
This page lists all example instances in the Lithuanian Lung Cancer Implementation Guide.
| Example | Description |
|---|---|
| diagnosticreport-lung-report-example | Complete LDCT screening report with LUNG-RADS 4A, solid nodule, coronary calcification |
| lung-composition-ldct-example | LDCT imaging composition with findings, impression, and recommendation sections |
| Example | Description |
|---|---|
| observation-lung-rads-4a-example | LUNG-RADS Category 4A (Suspicious) |
| observation-lung-rads-4as-example | LUNG-RADS Category 4A with S modifier |
| Example | Description |
|---|---|
| observation-pulmonary-nodule-solid-example | Solid nodule in right upper lobe (9mm, spiculated) |
| observation-pulmonary-nodule-part-solid-example | Part-solid nodule in left upper lobe |
| observation-pulmonary-nodule-ground-glass-example | Ground-glass nodule in right middle lobe |
| Example | Description |
|---|---|
| observation-incidental-coronary-calcification-example | Coronary artery calcification, moderate severity |
| observation-incidental-emphysema-example | Pulmonary emphysema, severe |
| observation-incidental-pleural-effusion-example | Bilateral pleural effusion |
| Example | Description |
|---|---|
| observation-lung-recommendation-3m-example | Recommendation for 3-month follow-up LDCT |
| observation-lung-recommendation-pulmonologist-example | Recommendation for pulmonologist consultation |
The lung cancer screening pathway uses resources defined in other Lithuanian FHIR IGs:
Vital Signs IG (anthropometrics collected during pre-examination):
Lifestyle IG (smoking history critical for lung cancer risk):